日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma.

靶向 LAG3/GAL-3 以克服免疫抑制并增强多发性骨髓瘤的抗肿瘤免疫反应

Bae Jooeun, Accardi Fabrizio, Hideshima Teru, Tai Yu-Tzu, Prabhala Rao, Shambley Aaron, Wen Kenneth, Rowell Sean, Richardson Paul G, Munshi Nikhil C, Anderson Kenneth C